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ABSTRACT 
 Acne is a prevalent skin disorder and is displayed through various different 
incidences. Cystic acne, a severe form of acne that is difficult to treat, reaches 
deep into the skin underneath the epidermis layer and produces painful, inflamed 
cysts that contain sebum, dead skin cells, and Propionobacterium acnes, the 
acne causing bacteria. Because this is an uncomfortable type of acne and is 
tough to treat, researchers have developed and tested a number of treatments to 
determine the best course of treatment for reducing and potentially eradicating 
cystic acne. These treatments are most commonly in the form of systemic or 
topical treatments, but other types of treatments are still considered as a possible 
course of action. According to this research, the most effective treatment that is 
currently available is isotretinoin, commonly known by the brand name Accutane. 
A short survey of medical professionals was conducted in order to determine 
what they most frequently prescribe when treating cystic acne and what the 
benefits and consequences of those treatments are. Their answers were 
compared to current research and determined that systemic Accutane is the 
most successful course of treatment for most patients with cystic acne due to the 
medications ability to reduce and potentially eradicate all cystic acne lesions. 
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I. INTRODUCTION  
Acne is a chronic skin condition that affects many people every year. This 
skin disorder has a high incidence and prevalence amongst all age groups. 
Cystic acne is a severe form of acne that causes unpleasant cysts on the 
face, chest, neck, back, or behind regions of the body and can lead to 
disfigurement. Determining a treatment for this form of acne may be an 
extensive and difficult process depending on the patient’s response to initial 
treatments. Because of this, researchers have discovered and developed 
many forms of treatments for cystic acne from systemic therapy to light 
therapy. The goal of this thesis is to discuss the basis of cystic acne and to 
evaluate the diverse treatments that are currently available. 
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II. THE ANATOMY OF THE SKIN  
In order to understand the genesis of acne, one must first understand 
the anatomy of the skin and the components that allow acne to form. The 
anatomy of the skin is broken down into three main layers: the epidermis, 
dermis, and subcutaneous tissue. These layers are listed from most 
superficial to the deepest layer. (See figure one). 
a. The epidermis layer, the outermost skin layer that can be easily observed, 
contains the sensory nerve endings as well as the pore openings and hair 
shaft (McKinley, O’Loughlin, Bidle, 2015). One of the main functions of the 
epidermis layer is to be the first line of protection from ultraviolet light, 
infections, and prevent detrimental damage to the integumentary system 
(Chu, 2012). This layer does not contain blood vessels or capillaries, but it 
does contain four to five layers of keratinized, stratified squamous 
epithelium (LeMaster, Matern, Morrison-Graham, etc., 2019). The keratin 
proteins within the epidermis skin cells assist in protection as well as cell 
migration, cell growth, transportation of resources, and recovery from 
injuries to the skin (Genetics Home Reference. 2019).  
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b. The dermis layer, which is the middle layer of the skin, is constructed of 
two layers of connective tissue (LeMaster, Matern, Morrison-Graham, etc., 
2019). The dermis contains the nerve fibers with sensory nerve endings 
branching off of the fibers and stretching into the top of the dermis layer, 
which is defined as the papillary layer (McKinley, O’Loughlin, Bidle, 2015). 
The bottom layer of the dermis is the reticular layer, which contains the 
majority of the appendages within the skin. The nerve fibers and sensory 
nerve endings allow the body to feel sensations on the skin whether the 
body is lightly touched or injured (American Academy of Dermatology, 
2013). The dermis layer also includes capillaries and the erector pili 
muscles. The capillaries within this layer provide the nutrients for the 
epidermis layer since that layer does not have capillaries or blood vessels 
(LeMaster, Matern, Morrison-Graham, etc., 2019). The erector pili muscles 
provoke the involuntary process that is observed as the hair on our body 
to “standing up” and the skin may exhibit a goose bump like texture when 
someone is cold or frightened. The scientific word for the hair rising is 
piloerection (Piloerection. (n.d.) Merriam-Webster). The most notable 
appendages located within the dermis layer of the skin are the sweat 
glands, sebaceous glands, and the hair follicles. The sweat glands are 
responsible for releasing sweat through the sweat gland duct to the sweat 
pore or hair follicle (McKinley, O’Loughlin, Bidle, 2015, pg. 201). Sweating 
assists the body by excreting sweat in order to cool the body down so that 
it does not overheat and cause damage (American Academy of 
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Dermatology, 2013). The sebaceous glands produce sebum, which is an 
oily secretion that is released onto the hair or within the hair follicle 
(McKinley, O’Loughlin, Bidle, 2015, pg. 202). This release is motivated by 
male and female sex hormones during puberty (McKinley, O’Loughlin, 
Bidle, 2015, pg. 202). Sebum assists in keeping the skin from drying out, 
creating a waterproof barrier, and may create a level complexion. 
However; an overproduction of sebum during puberty and other points in 
the human life span where hormones are produced in excess, such as 
menopause or pregnancy, may result in acne. 
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c. The subcutaneous layer, the deepest layer of the skin, consists of 
connective tissue such as areolar and adipose connective tissue, which 
insulate the body (McKinley, O’Loughlin, Bidle, 2015). The adipose tissue 
provides extra padding around the bodies muscles and bones and it also 
assists in regulating the body’s internal temperature by controlling whether 
or not heat is retained or released from the body (American Academy of 
Dermatology, 2013). The connective tissue within this layer is what 
connects the integumentary system to the body’s muscles and bones 
(American Academy of Dermatology, 2013). The veins and arteries that 
travel through the integumentary system are also located within the 
subcutaneous layer (McKinley, O’Loughlin, Bidle, 2015). The nerve cells 
from the dermis layer extend through the subcutaneous layer and travel 
through the body in order to relay information of touch and sensations to 
the brain (American Academy of Dermatology, 2013).  
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Figure 1: Diagram of the Skin Anatomy:  
 
McKinley, O’Loughlin, Bidle, 2015 
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III. ACNE VULGARIS 
Acne vulgaris is the medical term for common acne (The Free Dictionary). 
This skin condition is the most prevalent throughout the United States with an 
estimated number of forty to fifty million people who are affected (American 
Academy of Dermatology, n.d.). Acne affects approximately 85% of teenaged 
patients due to their increase in sex hormones during puberty (Ayer, Burrows, 
2006). Acne occurs more frequently in teenagers than in middle-aged adults 
because of the spike in hormone levels, however; anyone may experience 
acne at any age (American Academy of Dermatology, n.d). Both males and 
females are affected by acne, however; because women often experience 
more hormonal changes than men, women are more frequently affected by 
acne (American Academy of Dermatology, n.d). The changes in hormones in 
females that could lead to the formation of acne may be attributed to 
menstruation, pregnancy, menopause, and occasional hormone imbalances. 
Acne is caused by an overproduction of sebum and a build up of 
unnecessary substances on the skin the leads to clogged pores and hair 
follicles in the dermis layer of the skin (American Academy of Dermatology, 
n.d.). These unnecessary substances include certain skincare products, 
make-up, dead skin cells, and the acne causing bacteria, Propionobacterium 
acnes (American Academy of Dermatology, n.d.). These substances become 
trapped in a pore or a hair follicle along with excess sebum and are unable to 
escape (American Academy of Dermatology, n.d.). Therefore, this 
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combination of substances will form an inflamed pimple or nodule-like acne 
spot on the surface of the skin (American Academy of Dermatology, n.d.).  
The reason for an overproduction of sebum and the occurrence of P. 
acnes varies from patient to patient. Genetics, androgens (such as 
testosterone), stress, and excessive sweating are known causes that may 
affect the formation of acne (Ayer, Burrows, 2006). Endocrine disorders, such 
as polycystic ovarian syndrome,  a hormone disorder that affects growth and 
sexual hormones, are also capable of causing an acne breakout (Ayer, 
Burrows, 2006). Other factors that lead to etiopathogenesis that are not 
genetic or a part of a natural body function include smoking cigarettes and the 
ingestion of medicines and chemicals such as oral contraceptives, bromides, 
corticosteroids, and dioxins (Ayers, Burrows, 2006).  
Acne may appear in many different forms and severities depending on the 
patient’s hormone levels and sebum production. The blemishes often occur 
on the face, chest, neck, shoulders, back, the upper arms, or backside 
depending on the amount of friction, sweat, and sebum produced on these 
areas of the body (American Academy of Dermatology, n.d.).  
Researchers and medical professionals that work to develop and pinpoint 
the most effective treatments for acne recommend that this skin condition be 
treated as soon as possible in order to prevent acne scars and because it is 
better to determine what is the best method of treatment for the patient early 
on rather than later (Ayer, Burrows, 2006).  
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Treating acne is not a short-term situation. In order for patients to be 
equipped to handle their skin condition, it’s best to explore what treatment 
method would be the most comfortable for them to continue for a long period 
of time while still treating the skin inflammation caused by the acne lesions 
(Ayer, Burrows, 2006). The medical professional treating patients with acne 
should also inform them of appropriate cosmetic and hair products that will 
not aggravate the pre-existing acne or result in the formation of new acne 
lesions (Ayer, Burrows, 2006).  
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IV. TYPES OF ACNE 
Acne is displayed in various forms depending on the causes and potential 
hormone levels of an individual. Researchers have currently identified 
multiple different types of acne. The simplest known form of acne lesion is a 
comedo (WebMD), which is a hair follicle that is clogged with sebum and 
dead skin cells, and they are either an open or closed comedone. 
(Comedones are the plural form of comedo) (WebMD). An open comedo is 
also known as a blackhead and a closed comedo is known as a whitehead 
(WebMD). 
Blackheads are clogged pores in the skin that have a dark colored 
appearance (InformedHealth.org, 2013). The dark color is not due to a build 
up of dirt, but is a result of the skin pigment melanin reacting with oxygen in 
the air because blackheads are open comedones (InformedHealth.org, 2013). 
Blackheads are difficult to extract from the skin because the dead skin cells, 
sebum, and acne causing bacteria that make up this open comedo are not on 
the surface of the skin. A whitehead is a closed comedo with a small yellow or 
whiteish oil-filled bump (InformedHealth.org, 2013). Whiteheads are easier to 
extract because the oil-filled bump is easily popped by friction or pressure. 
Papules are a step up from whiteheads. Papules are the typical inflamed 
pimple that most people associate with acne, and they occur as small bumps 
across the affected area (InformedHealth.org, 2013). Another pimple or bump 
that is more serious than a papule is a pustule. A pustule is a bump filled with 
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yellow pus, and both papules and pustules may be popped to release the 
bumps contents (InformedHealth.org, 2013). 
A more severe type of acne that is more difficult to treat is nodular acne. 
The nodules are inflamed painful, reddish bumps on the skin that may feel 
like knots under the skin (Palmer, 2019). Nodules reach deep into the skin 
and while they may have a whitehead, they usually cannot be popped and will 
stay deep under the epidermis layer until the nodule is treated (Palmer, 
2019). Another type of severe acne, which is the focus of this paper, is cystic 
acne. Cystic acne is also an inflamed, red, and tender bump that reaches 
deep into the skin’s layers, however; it occurs as cysts within the skin instead 
of nodules (de Bellefonds, 2018). This type of acne will be discussed in depth 
further into the paper. 
A form of acne that is less well known amongst the general population is a 
severe form of acne known as acne conglobata. This type of acne includes 
multiple irritated nodules that form a connection under the skin and branch 
towards other nodules on the chest, neck, arms or the bottom regions of 
those affected (WebMD). Researchers have determined that this form of acne 
may affect men more often because of steroid or testosterone usage, and it 
may cause scarring (WebMD).  
A more common form of acne is acne mechanica, which occurs due to 
friction, pressure, and heat against the skin of the forehead due to frequent 
use of sports helmets and baseball caps (WebMD). Because the main source 
of this form of acne is related to sports equipment, acne mechanica is 
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common amongst athletes, and they have been encouraged to use absorbent 
materials under their helmets or caps and to shower shortly after wearing the 
equipment (WebMD).   
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V. CATEGORIES OF ACNE 
Dermatologists have narrowed down the types of acne to three different 
categories based on the amount of whiteheads, blackheads, irritated bumps, 
and lesions that occur on a persons skin (See figure two). The first category 
of acne is mild acne, which consists of blackheads and/or whiteheads 
(InformedHealth.org, 2013). A patient with mild acne will have fewer or 
smaller pimples than those with more intense acne, and therefore, mild acne 
will be easier to treat and clear up than others (InformedHealth.org, 2013).  
The second category of acne is moderate acne, which is normally treated 
by a dermatologist with a prescription medication in order to reduce the 
amount of lesions over time (WebMD). A patient with moderate acne will have 
more noticeable pimples as well as inflamed papules or pustules and this 
form of acne will be more difficult to treat (InformedHealth.org, 2013). 
The third category of acne is known as severe acne, which consists of 
papules, pustules, nodules, and cysts (InformedHealth.org, 2013). This 
category of acne often leads to the formation of acne scars because the types 
of acne involved are stubborn and difficult to treat (InformedHealth.org, 2013). 
In order to cure or reduce this form of acne, it has to be treated by a 
dermatologist who in particular situations, may prescribe strong topical or 
systemic acne treatments or sometimes inject a corticosteroid into a targeted 
nodule or cyst in order to reduce the inflammation (WebMD).  
 
 
A RISK BENEFIT ANALYSIS OF TREATMENTS FOR CYSTIC ACNE
 
   
18 
 
Figure 2: Categories of Acne 
Figure 2a: Mild Acne: 
       
https://www.webmd.com/skin-problems-and-treatments/acne/ss/slideshow-acne-dictionary 
 
 
 
 
Figure 2b: Moderate Acne: 
 
       
 
https://www.webmd.com/skin-problems-and-treatments/acne/ss/slideshow-acne-dictionary 
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Figure 2c: Severe Nodulocystic Acne: 
 
      
 
https://www.webmd.com/skin-problems-and-treatments/acne/ss/slideshow-acne-dictionary 
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VI. CAUSES OF CYSTIC ACNE 
Although there are many types of acne, this research is geared towards the 
formation and treatment of cystic acne. Cystic acne is defined in medical terms 
as severe acne with the formation of follicular cysts that are enclosed in a mixture 
of keratin and sebum, which may rupture and scar (The Free Dictionary). Acne 
cysts are present on the surface of the skin if the inflammation of the skin 
continues deep into the affected pore or hair follicle (American Academy of 
Dermatology, n.d) This inflammation is caused by the previously mentioned 
unnecessary substances, such as dead skin cells and P. acnes, and an 
overproduction of sebum (American Academy of Dermatology, n.d.). (See figure 
three) 
 A universal cause for the overproduction of sebum that causes cystic acne 
has not been determined yet due to the differences in lifestyles, skin types, and 
hormone levels. A key factor that may potentially play a role in the formation of 
acne for some patients is their diet. Researchers are still debating on whether or 
not an increase in sugar or sugary foods in a patient’s diet and an increase of 
insulin in the bloodstream due to the amount of glucose ingested could lead to 
acne formation (Huntley, 2003). This increase in insulin could create an increase 
in the production of endogenous sex hormones, such as testosterone and 
estrogen, and therefore the cells within the sebaceous glands could be 
stimulated and begin overproducing sebum, which may result in cystic acne 
(Huntley, 2003).  
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Researchers do know that a surge in hormones, such as those during 
adolescent teenage years, is one of the most prevalent elements that result in 
an overproduction of sebum and acne causing bacteria (MacGill, 2017). 
However; cystic acne is not restricted to teenagers and may affect all ages 
(MacGill, 2017). As previously mentioned when discussing the formation of 
general acne, certain hormonal fluctuations that are caused by oral and 
hormonal birth control implants, pregnancy, the menstrual cycle, stress, and 
other hormone therapies will also increase cystic acne production (MacGill, 
2017). High levels of humidity and the usage of lotions, cleansers, and make-
up that contain greasy or oily compounds may also result in the formation of 
cystic acne lesions (MacGill, 2017). If a person who is prone to cystic acne 
lesions is exposed to chemicals and drugs such as lithium, phenytoin, 
corticosteroids, and isoniazid he or she may notice an increase in cystic 
lesions as a form of reaction to these compounds (MacGill, 2017). However, 
for some cystic acne patients, their acne may occur due to a genetic 
disposition no matter their environment or exposure to acne triggering 
products (MacGill, 2017). 
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Figure 3: Diagram of Nodulocystic Acne Below the Skin: 
 
https://www.getproactiv.ca/on/demandware.static/-/Sites-Proactiv-Library/en_CA/content/images/your-
skin/nodule.jpg 
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VII. DIAGNOSIS & SYMPTOMS OF CYSTIC ACNE 
Cystic acne is diagnosed by having the lesions inspected by a medical 
professional such as a family medicine doctor, a dermatology physician 
assistant, or most likely, a dermatologist. The medical professional will 
observe the lesions and determine if they are cystic and also count the other 
acne lesions (open and closed comedones, papules, pustules, and nodules) 
to determine the degree of severity for treatment purposes (Cole, 2009). The 
lesions observed may be on the back, chest, or face of the patient (Cole, 
2009). (See figure four). 
The superficial symptoms of cystic acne lesions are characteristically 
described as red, painful to the touch, elevated bumps on the areas of the 
body that are acne prone (face, chest, and back) (Cole, 2009). A cystic lesion 
is normally accompanied by smaller lesions around the cyst, and therefore 
causes the affected area to be painful or sensitive (Cole, 2009). These 
lesions are also more visible than less severe forms of acne, which may lead 
to self-esteem issues over one’s appearance as well as a decline in mood 
(MacGill, 2017). This puts patients with cystic acne at a higher risk for 
psychological problems and emotional distress than those with a less severe 
form of acne (MacGill, 2017). Cystic acne may also result in permanent 
damage to the skin by producing scars in the form of either small, deep pits 
called “icepick scars,” shallow depressions in the skin, larger pits, or red, 
raised scars (MacGill, 2017).   
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Figure 4: An Example of Cystic Acne:  
 
https://optinghealth.com/wp-content/uploads/2017/07/Cystic-Acne-1-e1503829566899.png 
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VIII. TREATMENTS FOR CYSTIC ACNE 
Cystic acne falls under the category of severe acne, and therefore it may 
be difficult to determine a universally effective treatment for patients that 
suffer from this type of skin disorder. It may also be difficult to completely 
eradicate all lesions or scars produced especially if the treatment is not an 
effective match for the patient. Thankfully, there are many different forms of 
acne treatments such as systemic (oral antibiotics/medicines), topical 
(creams or gels), as well as light, vitamin, or herbal therapy.  
a. Systemic 
Systemic treatments have earned the title of the most common type 
of treatment for cystic acne because they are known to decrease 
swelling and reduce the redness that occurs with cystic lesions 
(American Academy of Dermatology). Some of the oral antibiotics 
known amongst the medical community that may treat cystic acne are 
doxycycline, trimethoprim-sulfamethoxazole, and Isotretinoin (Cole, 
2017). Female patients may also be prescribed an oral contraceptive, 
such as norethindrone, which is a progesterone pill used to balance 
female hormone levels (Cole, 2017).  
Oral doxycycline is the most prescribed oral tetracycline in the 
United States due to this antibiotic being a low risk medication for 
causing adverse reactions (Rosso, 2015). Doxycycline is a variation of 
the medication tetracycline, which is an antibiotic that may be used as 
treatment for various bacterial infections such as acne or sexually 
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transmitted diseases (Cunha, 2018). Doxycycline is capable of treating 
moderate-to-severe acne and is sometimes paired with extended-
release minocycline tablets in order to increase effectiveness and 
reduce side effects such as gastrointestinal issues, photosensitivity, 
and dizziness (Rosso, 2015). Doxycycline works by preventing further 
bacterial growth, and the medication kills bacteria while reducing the 
production of acne causing oils in the pores (MedlinePlus, 2017).  
Trimethoprim-sulfamethoxazole is another oral antibiotic used for 
treating moderate-to-severe acne, however; it is known to be a higher 
risk medication for adverse reactions, so it is only prescribed when 
other antibiotics, such as doxycycline, are not effective (Huntley, 
2003). Trimethoprim-sulfamethoxazole is also used to treat infections 
such as dysentery, urinary tract infections, pneumonia, and severe 
cases of chronic bronchitis (McCarty & Rosso, 2011). This medication 
has been compared to isotretinoin (to be discussed shortly) because it 
presents a similar response, but does not provide a long-term solution 
for preventing severe acne once the medication is no longer being 
administered (Huntley, 2003). Trimethoprim-sulfamethoxazole works 
by deterring the production of folates, which are salts or esters of folic 
acid required for bacterial DNA production (McCarty & Rosso, 2011).  
Isotretinoin, also known by the brand name Accutane, is defined as 
an oral acne treatment that is a derivative of vitamin A that exploits 
retinoid receptors, which are related to vitamin A, and there is no age 
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restriction on who may be prescribed this systemic treatment 
(Hitzeman, 2016). This is currently the most effective treatment for 
treating cystic acne because this drug is able to cutback on the amount 
of comedone production and sebum production on the surface and the 
pores and ducts within the dermis layer (Layton, 2009). This prevents 
the acne causing bacteria from reproducing in a hostile environment 
(Hitzeman, 2016). Antibiotics (in general) work by decreasing the cell 
growth within the sebaceous glands and are able to decrease the 
bacteria P. acnes and the inflammation that this bacteria causes 
(Hitzeman, 2016). Isotretinoin is not recommended as the first course 
of treatment to be prescribed for patients with moderate-to-severe 
acne because it is a teratogenic drug that posses a risk to the fetus if a 
female who is on the medication were to become pregnant  (Hitzeman, 
2016). Females on isotretinoin who are within childbearing years are 
required to use two forms of birth control if they are sexually active. 
They are also required to take two pregnancy tests before this 
medication is prescribed. This requirement continues every month 
while they are taking isotretinoin and one month after the patient has 
completed their prescribed dosage. The patient must also refrain from 
donating blood while on this medication to protect pregnant or soon to 
be pregnant women from receiving potentially harmful blood 
(Hitzeman, 2016).  
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Common side effects of isotretinoin include dry lips, eyes, and skin, 
including parts of the body other than those affected by acne lesions 
(Hitzeman, 2016). The medical professional prescribing this strong 
systemic treatment will recommend their patient to take the medication 
for a certain number of months based on the severity of their acne. 
This will be adjusted based on the patient’s progress and once they 
have completed their prescribed dosage. Isotretinoin is prescribed by 
medical professionals with hopes of eradicating most of the acne 
production and to decrease the inflammation of future breakouts 
(Layton, 2009).  
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b. Topical  
Systemic medications are known amongst the medical community 
as the most effective for treating severe acne. However; topical acne 
treatments are used more regularly than systemic ones and are usually 
prescribed prior to or in combination with systemic treatments (Penna, 
Ponti, Sparavigna, Tenconi, 2015). Topical acne treatments are 
typically prescribed to patients who suffer from mild-to-moderate acne, 
and it often take six to eight weeks to see a response (Freiman, Kraft, 
2011). Topical treatments may also be prescribed to prevent the side 
effects that sometimes occur during the use of systemic medications, 
such as gastrointestinal issues (Adawiyah, Priya, Roshidah, 2010). 
The most common side effects of topical acne treatments are skin 
irritation or dryness where the treatment has been applied (Freiman, 
Kraft, 2011). These may be soothed by including creams, face lotions, 
or ointments that are made for remedying dry and irritated skin into the 
patient’s skincare routine (Freiman, Kraft, 2011). Topical acne 
treatments are also prescribed in various forms of retinoids and 
antimicrobials (Freiman, Kraft, 2011). 
Retinoids are a derivative of vitamin A that are used to bind with 
nuclear receptors to regulate epithelial cell growth (skin cell growth) 
and are prescribed in either a gel, liquid, or cream form (American 
Osteopathic College of Dermatology). These medications encourages 
follicular keratinocytes in order to inhibit comedone formation by 
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unblocking clogged pores  (American Osteopathic College of 
Dermatology & Freiman, Kraft, 2011). The topical retinoids that are 
most frequently prescribed are adapalene, tretinoin, alitretinoin, and 
tazarotene (American Osteopathic College of Dermatology). Those 
being treated for cystic acne with a retinoid are requested to apply the 
medication in small amounts once daily approximately thirty minutes 
after washing their face (American Osteopathic College of 
Dermatology). Topical retinoids may also be used to treat 
hyperpigmentation such as acne scars as well as other skin conditions 
such as psoriasis (American Osteopathic College of Dermatology). The 
downfall of these medications is that while they can be used for 
treatment of inflammation caused by acne and acne scars, they are 
most commonly prescribed for patients with mild-to-moderate acne are 
not as effective as other known treatments for cystic acne (American 
Osteopathic College of Dermatology). 
Patients dealing with cystic acne may also be prescribed a topical 
antimicrobial to treat inflammation (Freiman, Kraft, 2011). The most 
common topical antimicrobial prescribed is benzoyl peroxide. Benzoyl 
peroxide assists in counteracting the antibiotic resistance of P. acnes 
while possessing anti-inflammatory characteristics and being able 
avert the formation of comedones (Freiman, Kraft, 2011). These 
medications are prescribed in numerous strengths depending on the 
patient’s experience and skin disorder. The strength reaches up to 
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10.0% benzoyl peroxide concentration, which may be more irritating to 
those who are not used to the effects of this treatment (Freiman, Kraft, 
2011). It is strong enough that it is able to bleach any fabrics with 
which it may come in contact, so this is a concern that some patients 
have before using this medication (Freiman, Kraft, 2011). Benzoyl 
peroxide kills P. acnes within the skin by emitting oxygen throughout 
the affected hair follicles and sebaceous glands (Freiman, Kraft, 2011).  
Other topical antimicrobials used include clindamycin and 
erythromycin because they may be tolerated more easily while still 
being able to decrease the number of inflamed acne lesions (Freiman, 
Kraft, 2011). However; when used alone and not in conjunction with 
benzoyl peroxide, these medications could increase the number of 
antibiotic resistant P. acnes in less than a month of use (Freiman, 
Kraft, 2011). Even though erythromycin and clindamycin have 
antimicrobial characteristics, antibiotic resistant Staphylococcus aureus 
and Staphylococcus epidermidis may form or increase in numbers in 
and around the part of the body being treated with one of these topical 
treatments (Freiman, Kraft, 2011). 
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c. Light Therapy 
Although systemic and topical acne treatments are the most 
recommended for treating cystic acne, researchers have tested 
different forms of light therapy for decreasing acne causing bacteria 
and inflammation. This research did observe patients whose acne had 
decreased inflammation after they experienced contact with natural 
sunlight (Adya, Inamadar, Pei, Tsoukas, 2015). It was determined that 
the porphyrins, which are produced naturally inside of the sebaceous 
glands by the P. acnes bacteria, were capable of absorbing light 
wavelengths between 400 to 700 nm (Adya, Inamadar, Pei, Tsoukas, 
2015). This absorption of light promotes photo-excitation of the 
porphyrins, which leads to the release of oxygen and free radicals that 
can cause bacterial suicide within the P. acnes (Adya, Inamadar, Pei, 
Tsoukas, 2015). Researchers have deduced that red lights, which 
have a longer wavelength, are capable of reaching deeper into the skin 
towards the sebaceous glands to focus on utilizing cytokine from 
macrophages to produce anti-inflammatory properties (Adya, 
Inamadar, Pei, Tsoukas, 2015). Blue lights are also able to decrease 
inflammation caused by acne, however; they are more effective when 
used in combination with red light (Adya, Inamadar, Pei, Tsoukas, 
2015). In order to determine the efficacy of light therapy, studies were 
done to compare subjects being treated with blue light or blue-red light 
therapy to those being treated with either a systemic or topical 
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treatment (Adya, Inamadar, Pei, Tsoukas, 2015). Studies were also 
done to test whether or not using light therapy in unison with other well 
known acne treatments would be beneficial for reducing acne 
inflammation (Adya, Inamadar, Pei, Tsoukas, 2015). After many 
experiments were done to compare blue and blue-red light therapy to 
other types of cystic acne treatment, it was determined that the light 
therapy was best used for treating mild-to-moderate cases of acne due 
to the severe inflammation that is caused by cystic acne lesions (Adya, 
Inamadar, Pei, Tsoukas, 2015). It was also determined that by 
incorporating light therapy along with, not in place of, systemic or 
topical acne treatments, a decrease in the number of lesions and 
severity of the inflammation could occur (Adya, Inamadar, Pei, 
Tsoukas, 2015). The light therapy was also credited with decreasing 
the sebaceous gland size and for cutting down sebum production 
(Adya, Inamadar, Pei, Tsoukas, 2015). However; if the distribution of 
the treatment is misused, there may be photothermal harm to the 
sebaceous glands as well as phototoxic damage to the skin due to 
improper exposure of light (Adya, Inamadar, Pei, Tsoukas, 2015). 
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IX. SURVEY OF MEDICAL PROFESSIONALS 
a. Objective 
The objective of the research conducted for this thesis was to 
evaluate the risks and benefits of the different methods of treatment for 
patients with cystic acne as well as to determine what treatment is 
most frequently prescribed to them. A simplified survey of medical 
professionals such as dermatologists, family medicine doctors, and 
dermatology physician assistants was performed in order to answers 
questions like, "Which type of treatment and what treatment method is 
used on a regular basis when treating cystic acne?" and, "Who treats 
patients with cystic acne and what do they use?”  
b. Methods  
The methodology of the interview process with the medical 
professionals was as follows: the medical professionals were selected 
from local Shelby medical practices as well as from medical practices 
in the Lake Norman-Charlotte area. In order to obtain enough data to 
evaluate, the initial number of intended interviewees was six to eight 
medical professionals. The professionals were contacted individually 
and asked if they would like to participate in answering a short survey 
about their experience with treating acne, specifically cystic acne. They 
were required to provide verbal consent in order to participate. If they 
declined, it was politely accepted and the researcher continued on to 
the next person. If they accepted, they were asked to provide verbal 
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consent to record the phone call and their answers for the survey 
questions through voice recording and typed notes. The phone calls 
were recorded in order to accurately remember their answers. A script 
was used to ask them for their verbal consent in order to offer 
reassurance to the professionals that their privacy would be protected 
and patient information would not be a topic of conversation in order to 
abide by HIPAA. HIPAA stands for the Health Insurance Portability and 
Accountability Act (Rouse, 2019). See appendix A to read the verbal 
consent script. Once verbal consent was acquired, they were asked to 
answer nine brief questions. See page appendix B to read the blank 
copy of the survey. If the professionals answered no to questions three 
or five, the survey ended because they did not have personal 
experience or treatment methods for cystic acne and their data would 
not apply to this research. The number of professionals who have 
treated cystic acne was recorded in a table along with their suggested 
treatments to determine if there is a link between the treatments. The 
reason for their recommendations on certain treatments was used to 
further answer the research questions. The medical professionals will 
be informed of this during the request for consent. The surveyed 
professionals are referred to as: subject 1, a dermatologist; subject 2, a 
dermatology PA; or subject 3, a family medicine doctor and so forth 
throughout the written and presentation portions of this thesis. Those 
who answered the survey were not informed of anyone else who was 
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interviewed or the other survey answers so that their responses were 
unbiased. The individual answers of the medical professionals are 
provided in appendix C.  
c. Responses 
Three medical professionals responded to the survey request and 
allowed their answers the answers to be recorded. It was noted that 
three was not the preferred number of participants for this survey, 
however; the three medical professionals that responded had some 
diversity amongst their professions.  
The first response was from a dermatologist who has been 
practicing medicine since 1997. He underwent a three-year 
dermatology residency and after medical school he became board 
certified. The majority of the dermatologist’s patients that have acne 
are teenagers, however; the dermatologist has also treated patients 
with acne up to eighty years old. A dermatologist’s job largely consists 
of treating patients with acne. Although other medical professionals are 
equipped to treat this skin disorder as well, patients with cystic acne 
are commonly referred to a dermatologist. Based on the 
dermatologist’s experience with treating cystic acne, they recommend 
systemic and topical acne medications that consist of isotretinoin. As 
previously mentioned, Accutane is the name brand of isotretinoin. The 
benefits of Accutane that have been observed by the dermatologist are 
that this medication is the closest researchers have been to finding a 
A RISK BENEFIT ANALYSIS OF TREATMENTS FOR CYSTIC ACNE
 
   
37 
cure for cystic acne and that 95% of patients who complete their 
suggested Accutane prescription do not have future breakouts. In 
order for a medical professional to prescribe Accutane or for a patient 
to be prescribed this medication, both must have an account with 
iPledge. iPledge is a program that was created in order to provide 
necessary information about Accutane such as the potential risks for 
both male and female patients as well as the potential concerns for 
depression (iPledge). The only consequences that this dermatologist 
considered for this medication are the political issues that have 
occurred due to the creation of iPledge and the stigmas that have been 
made about the medication potentially causing depression.  
The second response to this survey was a physician assistant who 
has been practicing dermatology since 2009. She went through a six-
month dermatology training program once she completed physician 
assistant school, and she does treat patients for acne in general as 
well as cystic acne. The average age range of patients that she treats 
for cystic acne is between thirteen to eighteen years old. When treating 
a patient that is troubled by cystic acne, the dermatology PA most 
frequently prescribes isotretinoin because she also believes that this 
medication can lead to complete clearance of acne. The dermatology 
PA concluded that the consequences of this treatment include dryness, 
teratogenicity, mood changes, blood work, and frequent dermatology 
appointments. She also mentioned that a patient taking Accutane may 
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have difficulty driving at night and muscle aches, which are two side 
effects that haven’t been discussed in the research collected for this 
thesis.  
The third and last response received for this survey was from a 
doctor that has been practicing family medicine since 2008.She does 
treat patients with acne, however; she did not undergo extra training to 
do so except for the general training they received in medical school 
and a four-week rotation in dermatology. The family medicine doctor 
does begin treatment for cystic acne and she commonly treat patients 
between the ages of twelve to fifty years old for this type of acne. The 
topical treatments that she frequently prescribes to treat cystic acne 
include Retin A, benzoyl peroxide, topical clindamycin, and adapalene. 
If these topical treatments are not effective, the doctor will refer the 
patient to a dermatologist so that the patient may be treated with 
Accutane. The doctor claimed that the benefit of topical treatments was 
that the patient will experience less systemic side effects, but the 
benefit of oral antibiotics is that they are more effective at treating deep 
cystic acne. The doctor also claimed that the benefit of Accutane is 
that it is more capable of eradicating cystic acne and preventing future 
lesions. She stated that consequence of topical treatments is that they 
do not entirely resolve the issues with deep cystic acne and that the 
consequence or oral antibiotics is that using this treatment may result 
in bacteria that are antibiotic resistant. She also noted that the 
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consequences of Accutane are the patient’s mucous membranes may 
become dry and that there are issues with teratogenicity in female 
patients if they become pregnant while on the medication. 
 
d. Conclusion of data 
The number of responses for this survey was not preferable for 
determining a universal treatment for cystic acne. However; there was 
some variation within medical backgrounds amongst the three 
professionals that responded. Therefore, the surveys did conclude that 
three different medical professionals with different levels of 
experiences all recommended Accutane as the most effective course 
of treatment for reducing and potentially eradicating cystic acne. Based 
on the survey responses, it was determined that the medical 
professionals believed that the outcome of this treatment outweighed 
the consequences. 
All of the professionals provided a verbal or written agreement to 
answer the survey and also allowed their answers to be recorded for 
research purposes. Out of the professionals surveyed, none of them 
answered no to questions number three or five so therefore all three 
surveys were permitted for use. The surveys provided were edited to 
provide a clear understanding of the answers, but the integrity of the 
answers was not disrupted. Overall, those that answered the survey 
were pleased to be able to provide useful information on this topic and 
to demonstrate their knowledge on acne treatments. 
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X. CONCLUSION  
Acne, specifically cystic acne, is difficult to treat without the guidance of a 
trained medical professional so it is helpful to know the options for treatments 
as well as the benefits and consequences of those treatments. The current 
treatments that are frequently used for decreasing cystic acne lesions are 
systemic, topical, and light therapy. As previously mentioned, and based on 
the research collected through online databases and the survey of medical 
professionals, systemic Accutane is the best course of treatment for severe, 
stubborn cystic acne over other acne treatments. This is the best course of 
treatment because it is the only known medication to this date that provides 
complete or almost complete clearance in patients with cystic acne. Also, 
despite the concerns that coincide with systemic medications and the 
potential side effects of Accutane, this medication received notable praise 
from the medical professionals that completed the survey used for this 
research. It was also determined through research that Accutane may not be 
the best course of treatment for every patient, so it is wise to seek medical 
advice on an initial medication prior to Accutane. By testing out other 
systemic or topical medications first, it will determine whether or not Accutane 
is necessary for that specific patient or not. As researchers and medical 
professionals continue to observe the effects of other medications, a new 
medication may later be determined as a more universal course of treatment 
for severe cystic acne, but for the time being, Accutane is the most effective 
when aiming to cure a patient’s cystic acne. 
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XII. APPENDIX 
APPENDIX A: VERBAL CONSENT SCRIPT 
“Good morning/afternoon Dr./Mr./Mrs. So-and-so. My name is Callie Elliott and I 
am a senior biology major at Gardner-Webb University. I am currently conducting 
research for my Honors thesis on treatments for cystic acne and I was wondering 
if you would do me the honor of participating in a short survey regarding how you 
treat this form of acne. The answers will be used to answer my thesis question as 
to who treats cystic acne, which type of treatment is used, and what treatments 
are most commonly used amongst medical professionals to treat this skin 
condition. Your name, medical practice, and graduate schools will not be 
documented and none of my questions will require patient specific answers in 
order to follow HIPAA regulations.” 
IF NO: “I understand, thank you for your time and have a blessed day.” 
IF YES: “Thank you for your consent Dr./Mr./Mrs. So-and-so. May I also have 
your consent to document your answers to the survey in a word document as 
well as to record this phone call so that I may reference the answers within my 
thesis?” 
IF NO: “I understand, in order to use your answers as a part of my research I will 
need to document them so that I may recall your methods of treatment when 
writing my thesis. If that is an issue, I will respect your privacy and I will not be 
able to conduct my survey with you today. Thank you for your time and have a 
blessed day.” 
IF YES: “Thank you again, I will now proceed with the survey” 
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APPENDIX B: BLANK SURVEY 
 
 
1. How long have you been practicing medicine?  
 
2. What is your medical specialty? 
 
3. Do you treat patients with acne?  
 
4. Did you receive extra training to treat patients with acne?  
 
5. Do you treat patients with cystic/severe acne?  
 
6. What age range do you treat most often for cystic acne? 
 
7. What treatment method do you recommend most often for cystic acne 
(severe)?  
 
8. What are the benefits of that treatment?  
 
9. What are the consequences of that treatment?  
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APPENDIX C: SURVEY RESPONSES 
Answers from the Dermatologist:  
1. How long have you been practicing medicine?  
He has been practicing medicine since 1997. 
2. What is your medical specialty? 
Their specialty is Dermatology.  
3. Do you treat patients with acne?  
Yes, he does treat patients with acne.  
4. Did you receive extra training to treat patients with acne?  
Yes, he went through three years of a dermatology residency with board 
certification. 
5. Do you treat patients with cystic/severe acne?  
Yes, he does treat patients with cystic/severe acne. 
6. What age range do you treat most often for cystic acne? 
He treats teenagers most frequently for cystic acne, but they may also 
treat patients up to eighty years old. 
7. What treatment method do you recommend most often for cystic acne 
(severe)?  
He recommends systemic, oral antibiotics or topical, isotretinoin  
8. What are the benefits of that treatment?  
He believes that the benefit of Accutane is that it is the closest to a cure 
for cystic acne. 95% of patients do not have reoccurrence after following 
the recommended usage. 
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9. What are the consequences of that treatment?  
He believes that there are no consequences other than the political issues 
that have occurred due to iPledge and the concerns over Accutane being 
a teratogenic drug because of societal concerns that have become more 
prevalent.  
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Answers from a Dermatology Physician Assistant:  
 
1. How long have you been practicing medicine?  
She has been practicing medicine since 2009 
2. What is your specialty?  
Her specialty is Dermatology  
3. Do you treat patients with acne?  
Yes, she does treat patients with acne. 
4. Did you receive extra training to treat patients with acne?  
Yes. She did a 6-month Dermatology training program after Physician 
Assistant School.  
5. Do you treat patients with cystic/severe acne?  
Yes, she does treat patients with cystic/severe acne. 
6. What age range do you treat most often for cystic acne?  
She treats patients in the age range 13-18 years old most frequently for 
cystic acne. 
7. What treatment method do you recommend most often for cystic acne 
(severe)?  
She recommends isotretinoin for treatment of severe acne. 
8. What are the benefits of that treatment?  
She believes that the benefit of Accutane is that this treatment usually 
allows for complete clearance of acne.  
 
 
A RISK BENEFIT ANALYSIS OF TREATMENTS FOR CYSTIC ACNE
 
   
51 
9. What are the consequences of that treatment?   
She concluded that there can be side effects for Accutane which include, 
but are not limited to, dryness, difficulty driving at night, teratogenicity, 
muscle aches, mood changes, frequent appointments, and blood work.   
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Answers from the Family Medicine Doctor:  
1. How long have you been practicing medicine?  
She has been practicing since 2008. 
2. What is your medical specialty? 
She practices Family Medicine 
3. Do you treat patients with acne? 
Yes, she treats patients with acne 
4. Did you receive extra training to treat patients with acne?  
No, she went through the general training through medical school and 
residency training, which included a 4-week rotation in Dermatology. 
5. Do you treat patients with cystic/severe acne?  
Yes, she does start treatment for cystic acne, but often refer patients to a 
dermatologist if it is severe or not responding to their treatments. 
6. What age range do you treat most often for cystic acne? 
She treats patients 12-50 years old for cystic acne 
7. What treatment method do you recommend most often for cystic acne 
(severe)?  
She recommends topical treatments such at Retin A, benzoyl peroxide, 
topical clindamycin, and adapalene to start out if the patient is not 
responding to minocycline or doxycycline. If all these fail, they usually will 
refer the patient to dermatology to look into Accutane. 
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8. What are the benefits of that treatment?  
The doctor stated that the benefit of using topical treatments only is the 
patient will experience less systemic side effects. The benefit of oral 
antibiotics is that they can more effective at eradicating deep cystic acne. 
The benefit of Accutane is that it is very effective at eradicating cystic acne 
and many times it does not return. 
9. What are the consequences of that treatment?  
The consequence of topical treatments only is that many times they do not 
completely resolve the deep cystic acne problem. The consequence of 
oral antibiotics is that bacteria can become resistant to the antibiotics and 
they no longer work. The consequence of Accutane is side effects of 
teratogenicity and drying of the mucous membranes 
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APPENDIX D: IRB APPLICATION 
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